Skip to main content
LITS logo
LITS
(NASDAQ)
Lite Strategy, Inc.
$1.09-- (--)
Loading... - Market loading

Lite Strategy (LITS) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Lite Strategy, Inc.
LITSNasdaq Stock MarketHealthcareBiotechnology

About Lite Strategy

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Company Information

CEOJustin File
Founded2000
Employees4
CountryUnited States
Fiscal YearJuly - June

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone858 369 7100
Address
9920 Pacific Heights Blvd., Suite 150 San Diego, California 92121 United States

Corporate Identifiers

CIK0001262104
CUSIP55279B301
ISINUS55279B3015

Leadership Team & Key Executives

Justin J. File CPA
Chief Executive Officer, Chief Financial Officer, Corporate Secretary and Director
Anne Frese
Chief People Officer
Dr. Robert D. Mass M.D.
Strategic Advisor